• DOI:10.1007/s00415-012-6669-1
Corpus ID: 21544457

Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson’s disease

@article{Sriram2012ValproateAA,
  title={Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson’s disease},
  author={Ashok Sriram and Herbert E. Ward and A. Hassan and Sanjay S. Iyer and Kelly D. Foote and Ramon L. Rodriguez and Nikolaus R. McFarland and Michael S. Okun},
  journal={Journal of Neurology},
  year={2012},
  volume={260},
  pages={521-527}
}

Ashok Sriram, Herbert E. Ward, +5 authors Michael S. Okun

Published 2012

Medicine

Journal of Neurology

It has been previously well established that the use of dopaminergic agents in Parkinson’s disease may contribute to behavioral disturbances such as dopamine dysregulation syndrome (DDS), impulse control disorders (ICD), and punding. ICD and punding have been most commonly addressed by reducing dose or by discontinuing the use of a dopamine agonist. Treatment of DDS has proven more challenging, and to date there has been no standard approach. In this paper, we review a series of four patients… CONTINUE READING

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed